From genetic mutations to molecular basis of heart failure treatment: An overview of the mechanism and implication of the novel modulators for cardiac myosin

Yu Jen Chen, Chian Shiu Chien, Chern En Chiang, Chen Huan Chen, Hao Min Cheng*

*此作品的通信作者

研究成果: Review article同行評審

7 引文 斯高帕斯(Scopus)

摘要

Heart failure (HF) is a syndrome encompassing several important etiologies that lead to the imbalance between oxygen demand and supply. Despite the usage of guideline-directed medical therapy for HF has shown better outcomes, novel therapeutic strategies are desirable, especially for patients with preserved or mildly reduced left ventricular ejection fraction. In this regard, understanding the molecular basis for cardiomyopathies is expected to fill in the knowledge gap and generate new therapies to improve prognosis for HF. This review discusses an evolutionary mechanism designed to regulate cardiac contraction and relaxation through the most often genetically determined cardiomyopathies associated with HF. In addition, both the myosin inhibitor and myosin activator are promising new treatments for cardiomyopathies. A comprehensive review from genetic mutations to the molecular basis of direct sarcomere modulators will help shed light on future studies for a better characterization of HF etiologies and potential therapeutic targets.

原文English
文章編號6617
期刊International Journal Of Molecular Sciences
22
發行號12
DOIs
出版狀態Published - 2 6月 2021

指紋

深入研究「From genetic mutations to molecular basis of heart failure treatment: An overview of the mechanism and implication of the novel modulators for cardiac myosin」主題。共同形成了獨特的指紋。

引用此